Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1362243-50-2 | MDL No. : | MFCD10000624 |
Formula : | C16H21BN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | AYWJWQSJIQZYEJ-UHFFFAOYSA-N |
M.W : | 284.16 | Pubchem ID : | 70700949 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.44 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 84.45 |
TPSA : | 36.28 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.01 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.85 |
Log Po/w (WLOGP) : | 2.23 |
Log Po/w (MLOGP) : | 1.65 |
Log Po/w (SILICOS-IT) : | 1.74 |
Consensus Log Po/w : | 1.69 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.59 |
Solubility : | 0.0736 mg/ml ; 0.000259 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.27 |
Solubility : | 0.152 mg/ml ; 0.000536 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.93 |
Solubility : | 0.00337 mg/ml ; 0.0000119 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.21 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); caesium carbonate In 1,4-dioxane; water at 100℃; for 16h; Inert atmosphere; | 35.b Step b. To a solution of tert-butyl 3-(5-bromoindoline-l-carbonyl)-3-fluoropyrrolidine-l-carboxylate (0.2 mmol), l-benzyl-5-(4,4,5,5-tetramethyl- l,3,2-dioxaborolan-2-yl)-lH-pyrazole (0.2 mmol) and CS2CO3 (0.6 mmol, 3eq) in 1,4-dioxane (1 ml) and water (0.2 ml) was added Pd(PPh3)4 (0.2eq) at rt under nitrogen. The reaction mixture was stirred at 100°C for 16 h. The resulting mixture was concentrated under reduced pressure. The resulting residue was purified by prep-TLC (PE:EtOAc=l: l) yielding tert- butyl 3 -(5 -( 1 -benzyl- 1 H-pyrazol-5 -yl)indoline- 1 -carbonyl)-3 -fluoropyrrolidine- 1 -carboxylate, which was used for next step directly without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; tris-(dibenzylideneacetone)dipalladium(0); cesium fluoride In 1,4-dioxane at 140℃; for 1h; Microwave irradiation; | Preparation of N-[2-(1-benzyl-1H-pyrazol-5-yl)phenyl]-8-fluoroquinolin-3-amine (compound I- 096) In a 5 mL micro-wave tube, 100 mg (0.32 mmol) of N-(2-bromophenyl)-8-fluoro-quinolin-3-amine, 108 mg (0.38 mmol) of 1-benzyl-5-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)pyrazole, 14.4 mg (0.016 mmol) of tris(dibenzylideneacetone)dipalladium, 13 mg (0.032 mmol) of 2-dicyclohexylphosphino-2',6'- dimethoxybiphenyl (SPhos) and 120 mg (0.79 mmol) of cesium fluoride were added in 3 mL of dry 1 ,4- dioxane. The resulting mixture was heated at 140°C for 1 h in micro-wave. The reaction mixture was cooled to room temperature, and then diluted with water and extracted with ethyl acetate. Combined organic layers were washed with brine, then dried over ChemElut cartridge and concentrated under vacuum. The residue obtained was purified by column chromatography on silica gel (gradient n- heptane/ethyl acetate) to yield 98 mg (78%) of N-[2-(1-benzyl-1 H-pyrazol-5-yl)phenyl]-8-fluoroquinolin- 3-amine as solid. LogP = 3.49 [Method A]. Mass (M+H) = 395. Purity= 98% (LC-210nm). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In tetrahydrofuran; water at 65℃; for 3h; Inert atmosphere; Sealed tube; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In tetrahydrofuran; water at 65℃; for 3h; Inert atmosphere; Sealed tube; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium carbonate In 1,4-dioxane; water at 100℃; for 2h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In tetrahydrofuran; water at 80℃; for 0.5h; Inert atmosphere; | 29.03 N-((1-aminoisoquinolin-6-yl)methyl)-5-(1-benzyl-1H-pyrazol-5-yl)nicotinamide M th l 5-(1-be zyl-1H- y azol-5-yl)nicotinate A stirred solution of methyl 5-bromonicotinate (250 mg, 1.16 mmol), 1-benzyl-5-(4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl)-1H-pyrazole (460 mg, 1.62 mmol) and potassium carbonate (320 mg, 2.31 mmol) in THF (5 mL) and water (100 mL) was degassed with N2 and then Pd(PPh34 (134 mg, 0.12 mmol) was charged and degassed again with N2. Reaction mixture was heated in the microwave at 80 °C for 30 min. Purification was performed by flash chromatography (0-100 % EtOAc in isohexane) to afford the title compound (265 mg, 55% yield) as a pale yellow-green viscous oil. [M+H]+ = 294.0 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In water; N,N-dimethyl-formamide at 80℃; for 12h; Inert atmosphere; |
[ 2377608-85-8 ]
1-Benzyl-4-bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.91
[ 2377608-85-8 ]
1-Benzyl-4-bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.91
[ 1007110-53-3 ]
1-Ethylpyrazole-5-boronic Acid Pinacol Ester
Similarity: 0.88
[ 2088458-40-4 ]
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole
Similarity: 0.87
[ 1282518-60-8 ]
1-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.86
[ 2377608-85-8 ]
1-Benzyl-4-bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.91
[ 2088458-40-4 ]
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole
Similarity: 0.87
[ 2377608-85-8 ]
1-Benzyl-4-bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.91
[ N/A ]
1-Benzyl-4-bromopyrazole-5-boronic acid, pinacol ester
Similarity: 0.91
[ 1007110-53-3 ]
1-Ethylpyrazole-5-boronic Acid Pinacol Ester
Similarity: 0.88
[ 2088458-40-4 ]
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole
Similarity: 0.87
[ 1876473-38-9 ]
1-(tert-Butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.86
[ 2377608-85-8 ]
1-Benzyl-4-bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.91
[ 1007110-53-3 ]
1-Ethylpyrazole-5-boronic Acid Pinacol Ester
Similarity: 0.88
[ 2088458-40-4 ]
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole
Similarity: 0.87
[ 1282518-60-8 ]
1-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.86
[ 847818-76-2 ]
1-Propyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.86